Wenzhong Zhou
Overview
Explore the profile of Wenzhong Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
421
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jia Z, Xin N, Liu J, Li Y, Yuan L, Guang D, et al.
Plant Dis
. 2024 Dec;
PMID: 39724043
The Asteraceae family plant Erigeron breviscapus (Vant.) Hand.-Mazz. (EBHM), commonly known as Dengzhan Asarum, was first recorded in the South Yunnan Materia Medica. E. breviscapus is widely utilized for treating...
2.
Peng R, Xie P, Jin Z, Zhou W, Wang Y, Chen X, et al.
J Clin Endocrinol Metab
. 2024 Dec;
PMID: 39715350
Context: Thyroid stimulating immunoglobulin (TSI) and thyrotropin receptor antibody (TRAb) are specific biomarkers for Graves' disease (GD), but their clinical characteristics are not fully understood. Objectives: To clarify the clinical...
3.
Zhang J, Yin G, Ye C, Feng M, Ji C, Zhou W, et al.
Chin J Cancer Res
. 2024 May;
36(2):124-137.
PMID: 38751436
Objective: Primary resistance to trastuzumab frequently occurs in human epidermal growth factor receptor 2 (HER2)-positive (+) breast cancer patients and remains a clinical challenge. Pyrotinib is a novel tyrosine kinase...
4.
Yin G, Liu L, Yu T, Yu L, Feng M, Zhou C, et al.
Genome Med
. 2024 Jan;
16(1):11.
PMID: 38217005
Background: Neoadjuvant chemotherapy (NAC) has become a standard treatment strategy for breast cancer (BC). However, owing to the high heterogeneity of these tumors, it is unclear which patient population most...
5.
Zhang M, Shi Z, Wu C, Yang F, Su T, Jing X, et al.
J Clin Endocrinol Metab
. 2023 Dec;
109(6):1474-1484.
PMID: 38157274
Context: Cushing syndrome (CS) is a severe endocrine disease characterized by excessive secretion of cortisol with multiple metabolic disorders. While gut microbial dysbiosis plays a vital role in metabolic disorders,...
6.
Zhou Y, Gui L, Wei W, Xu E, Zhou W, Sokolova I, et al.
Aquat Toxicol
. 2023 Feb;
256:106422.
PMID: 36773443
The environmental occurrence of nanoplastics (NPs) is now evident but their long-term impacts on organisms are unclear, limiting ecological and health risk assessment. We hypothesized that chronic exposure to low...
7.
Wang Y, Liu H, Yang T, Li A, Zhang C, Wu X, et al.
Rev Sci Instrum
. 2022 Dec;
93(11):115113.
PMID: 36461463
The China Spallation Neutron Source drift tube linac (DTL) is a high current intensity linear accelerator operated in pulsed mode. Beam loss is the most important cause of DTL performance...
8.
Ye L, Zhao Z, Ren H, Wang W, Zhou W, Zheng S, et al.
J Clin Endocrinol Metab
. 2022 May;
107(8):e3304-e3312.
PMID: 35512387
Context: Measurement of plasma steroids is necessary for diagnosis of congenital adrenal hyperplasia (CAH). We sought to establish an efficient strategy for detection and subtyping of CAH with a machine-learning...
9.
Meng X, Liu L, Xiang Y, Wang F, Yu L, Zhou F, et al.
Front Oncol
. 2022 Feb;
12:809570.
PMID: 35223490
Background: Leptin (LEP) plays a physiological role through its specific receptor (LEPR) and is involved in the occurrence and development of breast cancer. Our current study aimed at determining the...
10.
Ye C, Zhou W, Wang F, Yin G, Zhang X, Kong L, et al.
Int J Cancer
. 2021 Oct;
150(4):705-717.
PMID: 34648659
Because of the high heterogeneity of breast cancer outcome, identification of novel prognostic biomarkers is critical to improve patient stratification and guide precise treatment. We examined the prognostic value of...